Alliance to Advance MRI-Guided Ultrasound

This technology should provide excellent diagnostic accuracy and innovative image-guided therapy alternatives. The principal applications of this system will focus on women's health treatments including benign uterine fibroids and cancer, as well as malignant and benign tumors of the liver, kidney, pancreas, and bone.

"Combining Siemens' MRI technology with Haifu's unmatched clinical expertise in non-invasive, fast HIFU protocols will further the ability to identify and treat tumors, improving care options for doctors and patients alike,” said Nancy Gillen, vice president, MRI Division, Siemens Medical Solutions. "With innovations such as Tim [Total imaging matrix] technology and powerful applications, Siemens' MRI solutions provide the ideal partner with their ability to visualize disease states and thus allow for earlier treatment.”

The combination of MRI and HIFU enables improved visualization of tumor morphology and more precise thermal dose control, designed to reduce current treatment times.

"We are excited to partner with Siemens Medical Solutions to offer advanced HIFU technology, improving treatment options to our customers and the medical industry,” said Prof. Zhibiao Wang, president, Haifu. "Haifu has great international success with ultrasound-guided HIFU treatment and we believe using MRI as a guided imaging modality is the future of this technology, providing a new direction to advance tumor treatment.”





Related Links:
Siemens Medical Solutions
Chongqing Haifu Technology